120 related articles for article (PubMed ID: 32738753)
21. Ultrasonically guided transperineal seed implantation of the prostate: modification of the technique and qualitative assessment of implants.
van't Riet A; te Loo HJ; Ypma AF; Mak AC; van Slooten FH; Hoekstra CJ; Stenfert Kroese MC
Int J Radiat Oncol Biol Phys; 1992; 24(3):555-8. PubMed ID: 1399743
[TBL] [Abstract][Full Text] [Related]
22. Tissue composition and density impact on the clinical parameters for (125)I prostate implants dosimetry.
Oliveira SM; Teixeira NJ; Fernandes L; Teles P; Vieira G; Vaz P
Phys Med; 2014 Nov; 30(7):799-808. PubMed ID: 25239870
[TBL] [Abstract][Full Text] [Related]
23. Counterpoint: there is a dose-response relationship in the low-dose rate brachytherapy management of prostate cancer.
Stock RG
Brachytherapy; 2010; 9(4):293-6; discussion 299. PubMed ID: 20833593
[No Abstract] [Full Text] [Related]
24. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
Abboud F; Hollows M; Scalliet P; Vynckier S
Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
[TBL] [Abstract][Full Text] [Related]
25. MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.
Chibani O; Williamson JF
Med Phys; 2005 Dec; 32(12):3688-98. PubMed ID: 16475768
[TBL] [Abstract][Full Text] [Related]
26. Monte Carlo radiation dose simulations and dosimetric comparison of the model 6711 and 9011 125I brachytherapy sources.
Rivard MJ
Med Phys; 2009 Feb; 36(2):486-91. PubMed ID: 19291987
[TBL] [Abstract][Full Text] [Related]
27. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
Sadeghi M; Hamed Hosseini S
Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
[TBL] [Abstract][Full Text] [Related]
28. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
Miksys N; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):606-615. PubMed ID: 28126308
[TBL] [Abstract][Full Text] [Related]
29. Refining prostate seed brachytherapy: Comparing high-, intermediate-, and low-activity seeds for I-125 permanent seed prostate brachytherapy.
Delouya G; Bahary P; Carrier JF; Larouche RX; Hervieux Y; Béliveau-Nadeau D; Donath D; Taussky D
Brachytherapy; 2015; 14(3):329-33. PubMed ID: 25630619
[TBL] [Abstract][Full Text] [Related]
30. Impact of interseed attenuation and tissue composition for permanent prostate implants.
Carrier JF; Beaulieu L; Therriault-Proulx F; Roy R
Med Phys; 2006 Mar; 33(3):595-604. PubMed ID: 16878563
[TBL] [Abstract][Full Text] [Related]
31. Monte Carlo calculations of dosimetry parameters of the urocor prostaseed 125I source.
Li Z
Med Phys; 2002 Jun; 29(6):1029-34. PubMed ID: 12094972
[TBL] [Abstract][Full Text] [Related]
32. Seed fixity in the prostate/periprostatic region following brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
[TBL] [Abstract][Full Text] [Related]
33. Prostate brachytherapy. An overview.
Porter AT; Forman JD
Cancer; 1993 Feb; 71(3 Suppl):953-8. PubMed ID: 8428345
[TBL] [Abstract][Full Text] [Related]
34. The use of transrectal ultrasound placement of radioactive seeds for the definitive treatment of prostate cancer.
Zachow SE; Hargis R
J Miss State Med Assoc; 1996 Oct; 37(10):771-5. PubMed ID: 8908949
[TBL] [Abstract][Full Text] [Related]
35. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
Sowards KT; Meigooni AS
Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
[TBL] [Abstract][Full Text] [Related]
36. Fast GPU-based Monte Carlo simulations for LDR prostate brachytherapy.
Bonenfant É; Magnoux V; Hissoiny S; Ozell B; Beaulieu L; Després P
Phys Med Biol; 2015 Jul; 60(13):4973-86. PubMed ID: 26061145
[TBL] [Abstract][Full Text] [Related]
37. [Which modality for prostate brachytherapy?].
Bossi A
Cancer Radiother; 2010 Oct; 14(6-7):488-92. PubMed ID: 20724190
[TBL] [Abstract][Full Text] [Related]
38. Validation of K-edge 125I brachytherapy enhancement with silver compounds.
Young LA; Phillips MH; Nelson JA
Phys Med Biol; 1999 Aug; 44(8):1921-35. PubMed ID: 10473205
[TBL] [Abstract][Full Text] [Related]
39. Treatment of early stage prostatic cancer by implantation of iodine-125 seeds.
Lytton B; Schiff M; Shonk CR
Surg Clin North Am; 1980 Oct; 60(5):1215-23. PubMed ID: 7434162
[No Abstract] [Full Text] [Related]
40. Comparison of implant quality between loose and intra-operatively linked iodine-125 seeds in prostate cancer brachytherapy.
Jarusevicius L; Inciura A; Juozaityte E; Vaiciunas K; Vaitkus A; Sniureviciute M
J Radiat Res; 2012; 53(3):439-46. PubMed ID: 22739013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
